MAR vs STRO
Marriott International Inc (MAR) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MAR and STRO stock pages for the full models.
Not investment advice.